VARIBAR HONEY
Clinical safety rating: caution
Comprehensive clinical and safety monograph for VARIBAR HONEY (VARIBAR HONEY).
Barium sulfate is a radiopaque agent that absorbs x-rays, providing contrast in the gastrointestinal tract by coating the mucosal surface.
| Metabolism | Not metabolized; excreted unchanged in feces. |
| Excretion | Not applicable. VARIBAR HONEY is a non-absorbed barium sulfate suspension for oral or rectal administration. It is eliminated via fecal route: 100% unchanged in stool after gastrointestinal transit. No renal or biliary excretion occurs because the agent is not absorbed systemically. |
| Half-life | Not applicable. As a non-absorbed contrast agent, it does not have a systemic half-life. The gastrointestinal transit time is approximately 1-2 hours for small bowel follow-through and up to 24 hours for colonic transit. Clinical relevance: absence of systemic absorption precludes elimination half-life. |
| Protein binding | Not applicable. Barium sulfate is a non-absorbed, water-insoluble crystalline compound. It does not bind to plasma proteins because it remains within the gastrointestinal lumen and is not absorbed into the bloodstream. |
| Volume of Distribution | Not applicable. As a non-absorbed agent, it does not partition into body compartments. The volume of distribution is effectively the gastrointestinal lumen volume (approximately 3-5 L in adults). No systemic distribution occurs. |
| Bioavailability | Not applicable. Barium sulfate is not absorbed from the gastrointestinal tract; therefore, systemic bioavailability is 0% by both oral and rectal routes. The agent acts locally within the gastrointestinal lumen and is not intended for systemic absorption. |
| Onset of Action | Oral administration: Radiopacification of the gastrointestinal tract begins immediately upon ingestion, with visualization of the esophagus within seconds, stomach within 1-2 minutes, and small bowel within 15-30 minutes. Rectal administration: Colonic opacification is observed immediately after instillation (within 1-2 minutes). |
| Duration of Action | Oral administration: Gastrointestinal opacification persists for 1-2 hours during small bowel follow-through; colonic opacification may last up to 24 hours if retained. Rectal administration: Colonic opacification lasts for the duration of the enema (typically 15-30 minutes) and until evacuation; residual coating may persist for 1-2 hours post-evacuation. Clinical note: Duration is determined by gastrointestinal motility and the type of study (e.g., upper GI, small bowel follow-through, barium enema). |
| Molecular Weight | 600 |
Not applicable. Varibar Honey is a barium sulfate suspension for oral administration used as a contrast agent for GI imaging. No systemic dose; administered orally as directed by radiologist, typically 15-30 mL.
| Dosage form | SUSPENSION |
| Renal impairment | No adjustment necessary as barium sulfate is not absorbed systemically. |
| Liver impairment | No adjustment necessary as barium sulfate is not metabolized by the liver. |
| Pediatric use | Dose based on age and weight per institutional protocol; typically 5-15 mL orally for children. |
| Geriatric use | No specific adjustment required; use caution with aspiration risk. |
| 1st trimester | No human data; avoid in first trimester unless benefit outweighs risk. |
| 2nd trimester | Limited human data; use only if clearly needed. |
| 3rd trimester | Avoid near term due to potential neonatal hypothyroidism from iodine content. |
Clinical note
Comprehensive clinical and safety monograph for VARIBAR HONEY (VARIBAR HONEY).
| Placental transfer | Iodine crosses the placenta; degree depends on formulation and maternal status. |
| Breastfeeding | Iodine is excreted into breast milk and may cause neonatal hypothyroidism or goiter. Caution; use only if essential. |
| Lactation Rating | L3 |
■ FDA Black Box Warning
None
| Serious Effects |
Hypersensitivity to iodine or any componentHyperthyroidismThyroid nodulesDermatitis herpetiformisHypocomplementemic vasculitis
| Precautions | Risk of aspiration pneumonitis if aspirated into lungs; intestinal obstruction or perforation; careful use in patients with suspected gastrointestinal obstruction, perforation, or high risk of aspiration; hydration status monitoring to prevent impaction. |
| Food/Dietary | Patient must be NPO (nothing by mouth) for at least 6 hours prior to administration. After the procedure, maintain adequate hydration to prevent barium impaction. No specific food interactions beyond the pre-procedure fasting requirement. |
Loading safety data…
| Teratogenic Risk | VARIBAR HONEY contains barium sulfate, a non-absorbable radiopaque contrast agent. No human data on teratogenicity; animal studies not available. Barium sulfate does not cross the placenta in significant amounts due to lack of absorption. Fetal exposure is minimal; theoretical risk of fetal hypoxia if aspiration occurs. No specific trimester risks identified. |
| Fetal Monitoring | Monitor for signs of aspiration, particularly in patients with swallowing disorders or altered mental status. Assess for bowel obstruction or perforation. No fetal monitoring required. |
| Fertility Effects | No known effects on human fertility due to lack of systemic absorption. |
| Clinical Pearls |
| VARIBAR HONEY is a barium sulfate suspension (1% w/v) used for double-contrast upper GI series. Ensure patient is NPO for 6 hours prior. Administer effervescent granules first to distend stomach, then have patient sip VARIBAR HONEY while upright in right lateral decubitus position to optimize mucosal coating. Avoid using in patients with suspected GI perforation or known hypersensitivity to barium products. May cause constipation; hydrate post-procedure. |
| Patient Advice | Do not eat or drink for at least 6 hours before the exam. · You will receive effervescent granules to swallow before the barium preparation to expand your stomach. · The liquid has a honey-like consistency and may have a chalky taste. · You may experience temporary constipation or white stools after the procedure; increase fluid intake to prevent constipation. · Inform your doctor if you have a history of swallowing difficulties, bowel obstruction, or allergy to barium. |